Search Results (56)

Giant coronary artery aneurysms, defined as those with a diameter exceeding 8 mm or a four-fold increase relative to the reference vessel segment, are incredibly rare, with an estimated prevalence of approximately 0.02% in the general population. We present computed tomography angiography images of a thrombotic occlusion of a giant right coronary artery (RCA) aneurysm. An 80-year-old Caucasian man with chronic coronary artery disease, who had undergone percutaneous coronary intervention of the middle segment of the left circumflex artery (LCx) with drug-eluting stent implantation, was referred to the computed tomography department for coronary computed tomography angiography (CCTA) due to difficulty visualizing RCA during invasive coronary angiography. In CCTA, a giant aneurysm in the proximal segment of the RCA, with a massive thrombus, communicating with the typical origin of the RCA from the right aortic bulb sinus, then extending into the occluded part of the proximal segment of the RCA, was visualised. The maximum long dimension of the RCA aneurysm was 5.3 cm, and the maximum short dimension of the RCA aneurysm was 4.4 cm. The maximum thrombus thickness in the RCA aneurysm was 2.2 cm. The middle and distal segments of the RCA, presumably filled with collateral circulation, have significantly weaker contrast, and contain numerous predominantly calcified atherosclerotic plaques. In summary, the presented CCTA images confirm the clinical importance of this modality in diagnosing coronary artery aneurysms, even in situations where the results of invasive coronary angiography remain equivocal. Due to higher spatial resolution, the ability to perform image reconstruction in multiple planes, the ability to detect thrombus, and the ability to assess the vessel wall and extracoronary structures, CCTA not only enables the detection of coronary artery aneurysms but also enables risk prediction, thus enabling the planning of a more optimal treatment strategy. Full article

Background: The early identification of high-risk patients is crucial in stratifying treatment algorithms for Kawasaki disease (KD). Our study aimed to develop a new scoring system to predict the risk of developing a coronary artery aneurysm (CAA) and the persistence of giant CAA during follow-up. Methods: A retrospective cohort study included 151 patients treated at our institute for KD between 2011 and 2025. Results: A total of 25 patients (16.5%) developed CAA, while, in the follow-up period, aneurysms were registered in nine patients. Based on the values obtained from the univariate analysis, a scoring system was developed. It included age <6 months, IVIG treatment for >7 days, refractory KD, leucocytosis (>17 × 10⁹), neutrophilia (>16 × 10⁹), thrombocytosis (>400 × 10⁹), anaemia (<103 g/L), hypoproteinaemia (<54 g/L), and hypoalbuminaemia (<32 g/L). Patients with a score ≥5 had an almost nine-fold higher risk of developing CAA (OR 8.7, 95% CI 3.4–22.6; p < 0.001), while, if the score was ≥8, the risk for a chronic giant aneurysm was 71 times higher (OR 71.5, 95%CI 8.5–597.7; p < 0.001). Based on the ROC curve, a score ≥5 has 99% sensitivity and 70% specificity for the development of CAA (AUC = 0.87). A score ≥7 has 100% sensitivity and 85% specificity for the development of giant aneurysms (AUC = 0.87). Conclusions: The KawaCOR score is the first scoring system in our region specifically designed to predict the development of CAA and acute and chronic giant CAA. Full article

Background: The management of large (≥10 mm) and giant (≥25 mm) intracranial aneurysms remains clinically challenging due to their elevated rupture risk, morbidity, and procedural complications, which pose a dilemma for both intervention and conservative management. Flow diversion (FD) has emerged as a promising endovascular approach, although its comparative safety and efficacy versus Coiling remain unclear. Methods: Following PRISMA guidelines, studies published between January 2000 and March 2025 were identified across PubMed, EMBASE, Scopus, and Web of Science. Outcomes assessed included aneurysm recurrence, complete occlusion, favorable clinical outcomes, procedure-related complications and mortality. Odds ratios (ORs) with 95% confidence intervals (CIs) were calculated, and heterogeneity and publication bias were assessed. Results: A total of 1893 patients (1256 FD, 637 Coiling) and 1915 aneurysms across 33 studies were included. FD significantly reduced recurrence compared to Coiling (8% vs. 27%; p = 0.0001) and showed a trend toward a higher rate of complete occlusion (p = 0.0571). However, FD had a modestly increased rate of hemorrhagic complications (p = 0.0495). No other significant differences were found in clinical outcomes, major complications, ischemic events, delayed rupture, or mortality. Conclusions: Both FD and Coiling are effective and generally safe for large and giant intracranial aneurysms. FD is associated with lower recurrence and a trend toward a higher rate of complete occlusion, with similar overall safety but slightly higher hemorrhagic risk. FD is emerging as a preferred first-line option for large and giant unruptured aneurysms, while coiling remains important for ruptured aneurysms or when anatomical constraints limit the use of FD. Full article

Background/Objectives: “Ring-like” intracranial aneurysms—historically described as “doughnut-like” or “donut sign”—represent a rare configuration in which a central thrombus coexists with a circumferential mural flow ring. Traditionally considered a radiologic curiosity, this morphology likely reflects a shear-driven hemodynamic state rather than a stable organized thrombus. We aimed to summarize all PubMed-documented cases of ring-like aneurysms, define their morphologic and clinical spectrum, and assess their hemodynamic significance, rupture risk, and treatment outcomes. An additional aim is to formalize the use of the term “ring-like aneurysm” as a distinct morphologic subtype and to clearly differentiate it from the neuroradiologic “donut sign,” which represents an imaging appearance rather than a specific anatomic configuration. Methods: A systematic PubMed search (1996–2024) was conducted using the following combinations of keywords and Boolean operators: (“ring-like aneurysm” OR “donut aneurysm” OR “doughnut aneurysm” OR “ring-shaped aneurysm” OR “circumferential lumen” OR “central thrombus”) AND (“intracranial” OR “cerebral” OR “basilar” OR “aneurysm”). Only English-language, PubMed-indexed reports describing true ring-like (donut-shaped) aneurysms were included. Non-indexed, non-English, and serpentine or fusiform aneurysms mimicking ring-like morphology were excluded. Extracted data included aneurysm location, size, presentation (ruptured, symptomatic, or incidental), treatment strategy, and clinical outcome. Statistical proportions were analyzed using descriptive methods, Wilson 95% confidence intervals, and a binomial test to compare the observed subarachnoid hemorrhage (SAH) rate against the expected conservative rupture proportion. Results: The search identified 16 individual patients reported in 10 publications. All aneurysms were large or giant (14–36 mm) displaying characteristic thrombosed pattern. Ruptured presentation occurred in 6 out of 16 cases (37.5%) and symptomatic unruptured in 10 (62.5%). No incidental cases were reported. Posterior circulation involvement was present in 44%, with a female predominance of 69%. Conclusions: Ring-like aneurysms constitute a distinct, shear-maintained hemodynamic entity combining mural jet flow with central thrombosis. Their frequent symptomatic or ruptured presentation supports the concept that this morphology represents a pre-ruptural configuration rather than a chronic thrombotic residue. Early recognition and targeted endovascular exclusion of the inflow zone are essential to prevent delayed rupture. Full article

Background: The best treatment for children with KD who fail to respond to the first dose of IVIG (refractory KD) is currently unknown. The purpose of this study was to determine treatment practices of pediatric rheumatologists in North America who manage IVIG-refractory KD. Methods: A 34-item web-based survey was sent to 102 randomly selected members of the Childhood Arthritis and Rheumatology Research Alliance (CARRA). The anonymous survey addressed the use of primary intensification as well as the treatment of IVIG-refractory KD. Results: The response rate was 82%; 56% (all pediatric rheumatologists) completed the survey. Primary intensification was used for macrophage activation syndrome (MAS), KD shock, and those at high risk for coronary artery aneurysms (CAAs) by 84%, 76% and 52% of responders, respectively, with corticosteroids (CSs) used most frequently. For IVIG-refractory KD without CAA, a second dose of IVIG was used most often (63% alone; 23% plus CS). With non-giant CAAs, only 15% used a second IVIG alone, 40% used IVIG plus CS, and 35% took infliximab, usually with CS/IVIG. With giant CAA, treatments used most frequently were CS, a second IVIG, and infliximab (91%, 69%, and 58%, respectively), usually as combinations of two or more medications. Conclusions: Treatment of IVIG-refractory KD varies significantly among North American pediatric rheumatologists, particularly in the presence of CAAs. Our findings emphasize the need for research to identify the most effective therapy for this KD subgroup. The current use of primary intensification and the presence and size of the CAA will need to be considered as consensus treatment plans are developed. Full article

Background/Objectives: Giant atrial chambers are rare but clinically important conditions, most often linked to rheumatic mitral valve disease, though they may also occur in congenital or other acquired disorders. Despite their low prevalence, they entail major hemodynamic, arrhythmogenic, and extracardiac risks. This study aimed to review recent evidence on giant atrial pathology—including giant left atrium (GLA), giant right atrium (GRA), and atrial appendage aneurysms—and to illustrate its relevance through cases of symptomatic extracardiac compression. Methods: A PubMed search on 15 September 2025 using “giant atrium” and limited to human, free full-text studies from the last 10 years yielded 93 results. After screening, 21 reports describing 24 cases were analyzed and compared with institutional experience. Results: GLA is most often defined by an anteroposterior diameter ≥6.5 cm or ≥8 cm, while criteria for GRA and appendage aneurysms remain inconsistent. Reported complications include atrial fibrillation, thromboembolism, and compression of mediastinal structures, with presentations such as dysphagia or airway obstruction. While valve surgery alone may suffice, many authors recommend concomitant atrial reduction or aneurysm resection in symptomatic patients. Conclusions: Giant atrial pathology, though uncommon, carries significant cardiac and extracardiac implications. Management should be individualized, and awareness of atypical manifestations is critical for timely diagnosis and treatment. Full article

Background and Objectives: To evaluate factors affecting aneurysm rupture, present our surgical experience with intracranial aneurysms, specifically using the picket-fence clipping technique for giant aneurysms, and highlight the complementary roles of sodium fluorescein (Na-Fl) and indocyanine green (ICG) videoangiography in enhancing surgical precision and patient outcomes. Materials and Methods: We retrospectively analyzed 47 patients who underwent microsurgical clipping of intracranial aneurysms with intraoperative Na-Fl and ICG videoangiography between September 2015 and February 2024. We assessed relationships between patient comorbidities, family history of subarachnoid hemorrhage (SAH), smoking history, aneurysm location and size, and SAH occurrence. Concordance between intraoperative videoangiography and postoperative digital subtraction angiography (DSA) for detecting residual aneurysms was also evaluated. Results: Of the 47 patients (31 female, 16 male; mean age 51.78 ± 11.16 years), 11 (23.4%) presented with SAH. The most common aneurysm location was the middle cerebral artery (MCA) (68.1%). Hypertension and smoking history were significantly higher in the hemorrhage group (p < 0.05). Aneurysm size and anterior communicating artery (AComA) location were also significantly associated with hemorrhage (p < 0.05). Aneurysm size demonstrated significant discriminative power for hemorrhage [AUC: 0.884 (0.827–0.941)], with a cutoff of 7.1 mm yielding 90.9% sensitivity and 94.4% specificity. Five giant MCA aneurysms were treated with the picket-fence technique, with intraoperative ICG and Na-Fl confirming parent artery patency and complete aneurysm occlusion, subsequently confirmed by postoperative DSA. Small remnants were detected in 2 cases (4.26%) on postoperative DSA, both in distal ACA aneurysms, which were also detected by intraoperative videoangiography. Conclusions: Hypertension, smoking history, aneurysm size, and location were important predictors of aneurysm rupture. Intraoperative ICG and Na-Fl videoangiography provide real-time, high-resolution visualization crucial for complex intracranial aneurysm surgery, including the picket-fence technique for giant aneurysms. Their complementary use enhances surgical safety, guides intraoperative decision-making, and contributes to improved outcomes in challenging cases. Full article

Coronary artery aneurysms (CAAs) are an uncommon finding, and their rupture is an exceedingly rare and life-threatening complication. Giant aneurysms of the left main coronary artery (LMCA) pose a significant diagnostic and therapeutic challenge. We describe the case of a 62-year-old male who presented with acute coronary syndrome and was subsequently diagnosed with a ruptured giant LMCA aneurysm causing cardiac tamponade and multi-organ dysfunction. The initial diagnosis was suggested by coronary angiography and confirmed with contrast-enhanced multidetector computed tomography (MDCT) and echocardiography. The patient underwent emergency surgery consisting of aneurysm excision, thrombectomy, ligation of the LMCA ostium and its distal branches (LAD and circumflex), and coronary artery bypass grafting (CABG) using the left internal thoracic artery to the left anterior descending artery and a saphenous vein graft to a marginal branch. The patient’s postoperative course was complicated by transient multi-organ dysfunction, which resolved. He was discharged in a stable condition. This case highlights the critical importance of rapid multimodal imaging for diagnosis and the feasibility of emergency surgical intervention to achieve a favorable outcome in patients with a ruptured giant LMCA aneurysm. Full article

Background: The term ‘left atrial appendage aneurysm’ (LAAA) has been recognized since 1962, when it was first described. It is an exceedingly rare pathology that can affect both adults and children. Often asymptomatic, it may be discovered incidentally. The anomaly consists of an exaggerated dilation of the primitive portion of the left atrium, resulting from pectinate muscle dysplasia or as a consequence of an obstructive lesion between the left atrium and the mitral valve. Surgical intervention represents a reliable strategy for preventing catastrophic complications such as stroke, thromboembolism, and rupture. This is a very rare condition, which is why we aimed to present a case report along with a review of the literature. Case presentation: We report the case of a 6-year-old asymptomatic girl in whom a giant left atrial appendage aneurysm was incidentally detected during a routine transthoracic echocardiogram, associated with a small atrial septal defect and a prothrombotic genetic profile. The aneurysm was successfully excised, and the atrial septal defect was closed. The postoperative course was uneventful, and the patient was discharged home on the 8th postoperative day. Conclusions: Left atrial appendage aneurysm is rare in children and often asymptomatic, yet it may be life-threatening due to stroke or thromboembolism. Fetal echocardiography may be considered in selected high-risk pregnancies, and routine postnatal assessment is advised, with surgical intervention recommended particularly for patients with risk factors for thrombus formation in the left atrium or its appendage. Full article

Background/Objectives: Denosumab has been considered effective for downstaging giant cell tumor of bone (GCTB), implying that it lowers the Campanacci grade rather than reducing tumor size. Preoperative tumor shrinkage holds therapeutic value by decreasing surgical complications. While previous studies have observed lesion shrinkage in some patients, no study has identified the types of patients likely to show treatment response. Thus, we sought to identify the clinical factors associated with post-denosumab GCTB size reduction. Methods: The data for 45 GCTB patients (29 females [64%], 16 males [36%], median age 32 years [range: 17–65]) who received denosumab were analyzed. Lesions were in the extremities (n = 25, 56%) or spinopelvic region (n = 20, 44%). Ten (22%) were recurrent. Lesion size reduction was assessed using two criteria: a ≥5% and a ≥5 mm decrease in the longest diameter. Univariate analyses were conducted for all variables, and those found to be significant were subjected to multivariate analyses. In addition, multicollinearity was evaluated. Subgroup analyses were performed based on lesion location and recurrence status. Results: Campanacci grade III predicted proportional shrinkage (≥5%) in all patients (OR 4.819, 95% CI 1.121–20.714) and in extremity (OR 11.171, 95% CI 1.023–122.014) and primary lesions (OR 5.781, 95% CI 1.181–28.297), and aneurysmal bone cyst (ABC)-like change was associated with absolute shrinkage (≥5 mm) in all patients (OR 8.734, 95% CI 1.159–65.845) and primary lesions (OR 11.936, 95% CI 1.074–132.69). The longest tumor diameter of ≥7 cm predicted absolute shrinkage in all patients (OR 12.380, 95% CI 1.038–147.694) and for spinopelvic lesions (OR 20, 95% CI 1.676–238.63). Conclusions: ABC-like change, Campanacci grade III, and the longest tumor diameter might predict post-denosumab GCTB shrinkage in all patients, though shrinkage varies with lesion location and recurrence status. These factors could help clinicians tailor treatment strategies in different settings. Further research is needed to explore how clinical factors pharmacologically influence denosumab-induced GCTB shrinkage. Full article

Introduction: The transforming growth factor beta (TGF-β) signaling pathway plays a critical role in cellular processes, including maintaining vascular integrity and regulating vascular remodeling. Aneurysm rupture is associated with pathological changes in the arterial wall. Aims: We aimed to investigate the gene expression of transforming growth factors (TGFB1, TGFB2, TGFB3) in peripheral blood mononuclear cells (PBMCs) isolated from the blood of patients with unruptured intracranial aneurysms (UIAs) and ruptured intracranial aneurysms (RIAs), and from a control group. Additionally, we evaluated serum levels of TGF-β1, TGF-β2, and TGF-β3 and analyzed their associations with various risk factors, including sex, age, aneurysm size, number, shape, smoking, and hypertension. Materials and Methods: The study group consisted of patients diagnosed with intracranial aneurysms (IAs) who were eligible for embolization at the Department of Neurosurgery, Clinical Hospital of the Medical University of Bialystok. The control group consisted of healthy volunteers, recruited from the employees of the Clinical Hospital of the Medical University of Bialystok. Expression levels were assessed using quantitative real-time polymerase chain reaction techniques in PBMCs. Serum concentrations of TGF-β isoforms were evaluated using a multiplexed bead-based immunoassay. Results: Among 32 patients, 24 had unruptured intracranial aneurysms (UIAs), including 18 women and 6 men, while 8 presented with ruptured intracranial aneurysms (RIAs), evenly distributed between women and men (4 each). The mean age of the patients was 53 years (range: 24–71 years). The control group consisted of 20 healthy volunteers, 14 females and 6 males, with a mean age of 51 years (range: 24–71 years). The expression of TGFB1 was significantly higher in the IA versus C group, but TGFB3 expression was significantly higher in the RIA versus C group. The serum level of TGF-β1 and TGF-β3 was significantly higher in the RIA versus UIA group. Serum TGF-β1 levels were higher in men and individuals < 60 years of age. Positive correlations were observed between serum TGF-β1, TGF-β3 and aneurysm size, with significantly higher TGF-β3 levels in patients with giant aneurysms. Conclusions: Our study highlights the distinct roles of TGFB1 and TGFB3 in aneurysm pathophysiology, identifying TGFB1 as a molecular contributor to aneurysm formation and TGFB3 with rupture. Increased serum TGF-β1 and TGF-β3 concentrations could serve as promising noninvasive parameters for assessing the risk of aneurysm rupture. Further research with larger cohorts is needed to define cut-off values and validate the method, enabling the use of blood TGF-β levels as a tool for clinical decision-making. Full article

Background: A popliteal vein aneurysm (PVA) is a rare vascular abnormality that can lead to the formation of venous thrombi, resulting in potentially life-threatening pulmonary embolism (PE). Methods: We present the case of a 30-year-old female who presented with recurrent pulmonary embolism complicated by cardiorespiratory arrest. Emergency thrombolysis was initiated, which successfully stabilized the patient. Further diagnostic evaluation, including imaging studies, revealed the presence of a giant popliteal vein aneurysm (60/70 mm) as the underlying cause of recurrent embolism. Results: The patient underwent surgical repair of the popliteal vein aneurysm to prevent further thromboembolic events. The procedure was performed successfully, and the patient recovered favorably. Conclusions: This case underscores the importance of recognizing PVA as a potential cause of recurrent PE, particularly in young patients without typical risk factors. Full article

Background/Objectives: Left ventricular (LV) pseudoaneurysm is a rare but life-threatening complication after acute myocardial infarction, often resulting from inadequate excision of damaged myocardium and use of only a xenopericardial patch during primary LV free wall rupture repair. Methods: A 62-year-old female developed a giant LV pseudoaneurysm one year after initial surgical repair of a free wall rupture with a xenopericardial patch. Imaging confirmed a large pseudoaneurysm with a broad neck and mural thrombus. She underwent pseudoaneurysmectomy, LV reconstruction with a Dacron patch overlaid by a xenopericardial patch, and concomitant mitral and tricuspid valve repair. Results: Surgical exploration revealed a broad-necked pseudoaneurysm and dehisced patch material. The aneurysm was resected, and the LV was reconstructed, resulting in the exclusion of the pseudoaneurysm and improvement of the shape and function. The patient recovered uneventfully and was discharged in good clinical condition with restored LV function. Conclusions: Pseudoaneurysm formation after LV free wall rupture repair is often due to insufficient resection and the use of only a xenopericardial patch. Surgical management with complete excision, Dacron patch reconstruction, and xenopericardial reinforcement facilitates the favorable remodeling of LV geometry and function, and reduces the risk of recurrence. Full article

Giant intracranial aneurysms are frequently treated shortly after discovery due to their increased risk of rupture and commonly symptomatic nature. Among available treatments, flow diverters are often the sole viable option, though they carry a rare but serious risk of delayed post-operative rupture. The underlying mechanisms of these ruptures remain unknown, due to the biomechanical complexity of giant aneurysms and challenges in replicating in vivo hemodynamic conditions within numerical simulation frameworks. This study presents a novel fluid–structure interaction simulation of a giant intracranial aneurysm treated with a flow diverter, based on high-resolution rotational angiography imaging. The resulting hemodynamics are compared to three established delayed-rupture hypotheses involving pressure rises, chaotic flow and autolysis. When considering wall compliance, the analysis reveals a consistent phase shift, dampening in pressure cycles, and an increased aneurysmal flow. These findings highlight the need for revisiting existing hypotheses and provide a foundation for advancing both computational modelling and clinical management strategies for giant intracranial aneurysms. Full article

Kawasaki disease (KD) with coronary artery aneurysms (CAAs) is currently the primary cause of childhood acquired heart disease with an unclear pathogenesis. We established five groups for the discovery of differentially expressed proteins (DEPs): healthy control, febrile control, KD without CAAs, KD with small and medium CAAs, and KD with giant CAAs (n = 8 in each group). The validation of selected DEPs was conducted in another five groups (n = 4 in each group). We conducted comprehensive bioinformatics analyses to elucidate the functional roles of the DEPs in the groups of KD with CAAs and KD without CAAs. A total of 104 DEPs were identified in KD patients, which were primarily associated with complement-related pathways. A trend analysis of these 104 DEPs revealed 54 significantly changed DEPs associated with increased disease severity, which were primarily associated with G-protein-related functions. The alterations in α-1-antitrypsin short peptide (SERPINA1) and guanine nucleotide-binding protein G(i) subunit alpha-2 (GNAI2), which were selected from complement-related and G-protein-related pathways, respectively, were validated by Western blotting, and they were significantly decreased in KD patients with vs. without CAAs. In addition, we conducted an analysis of the DEPs in the groups of KD with CAAs and KD without CAAs, separately. There were 91 DEPs specifically expressed in KD patients with CAAs, associated with the neutrophil extracellular trap and complement pathways, while 16 DEPs were specific to those without CAAs, associated with viral infection and immunity pathways. Additionally, for DEPs among different severities of CAAs, there were 102 DEPs in KD patients with small and medium CAAs, associated with complement pathways and platelet activation pathways, whereas 34 DEPs were specific to giant CAAs, associated with the Rap1 signaling pathway and cell functions. In conclusion, this study provides plasmatic exosomal protein profiles in KD patients with CAAs, suggesting that SERPINA1 and GNIA2 might serve as novel potential diagnostic biomarkers for KD with CAAs. Full article